Bilateral breast carcinoma : Risk factors and outcomes for patients with synchronous and metachronous disease
β Scribed by Dwight E. Heron; Lydia T. Komarnicky; Terry Hyslop; Gordon F. Schwartz; Carl M. Mansfield
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 345 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary breast carcinoma. Alteration of the p53 gene causes down-regulation of the expression of thrombospondin-1, a natural inhibitor of angiogenesis. This study was conducted to investigate the association between
## Background: When found in an otherwise benign biopsy, lobular carcinoma in situ (lcis) has been associated with an increased risk of development of a subsequent invasive breast carcinoma. however, the association between lcis and the risk of subsequent local recurrence in patients with infiltrat
## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly